Cargando…
APEX1 Expression as a Potential Diagnostic Biomarker of Clear Cell Renal Cell Carcinoma and Hepatobiliary Carcinomas
Apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APEX1) has been known to play key roles in DNA repair, the regulation of diverse transcriptional activity, and cellular responses to redox activity. This study aimed to examine serum APEX1 (s-APEX1) expression as a possible screening biom...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723795/ https://www.ncbi.nlm.nih.gov/pubmed/31375000 http://dx.doi.org/10.3390/jcm8081151 |
_version_ | 1783448853336293376 |
---|---|
author | Kim, Ji-Myung Yeo, Min-Kyung Lim, Jae Sung Song, In-Sang Chun, Kwangsik Kim, Kyung-Hee |
author_facet | Kim, Ji-Myung Yeo, Min-Kyung Lim, Jae Sung Song, In-Sang Chun, Kwangsik Kim, Kyung-Hee |
author_sort | Kim, Ji-Myung |
collection | PubMed |
description | Apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APEX1) has been known to play key roles in DNA repair, the regulation of diverse transcriptional activity, and cellular responses to redox activity. This study aimed to examine serum APEX1 (s-APEX1) expression as a possible screening biomarker for clear cell renal cell carcinoma (ccRCC), hepatocellular carcinoma (HCC), and proximal and distal cholangiocarcinoma (CC). A total of 216 frozen serum samples were collected from 39 healthy control cases, 32 patients with ≥58 copies/mL of hepatitis B viral DNA (HBV DNA (+)), 40 ccRCC cases, 59 HCC cases, and 46 CC cases. The serum samples were examined for s-APEX1 concentration by enzyme-linked immunosorbent assay. The association of APEX1 expression with clinicopathological characteristics was also studied by immunohistochemical staining in 106 ccRCC, 131 HCC, and 32 intrahepatic CC cases. The median s-APEX1 concentrations of the HCC, CC, ccRCC, healthy control, and HBV DNA (+) groups were 0.294, 0.710, 0.474, 0.038, and 2.384 ng/mL, respectively (p < 0.001). Univariate and multivariate analyses revealed that increased cytoplasmic APEX1 expression led to a shorter disease-free survival period in HCC and CC cases. We suggest that the s-APEX1 level could be a potential diagnostic biomarker of ccRCC, HCC, and CC. Additionally, cytoplasmic APEX1 expression in cancer cells could be used to predict relapses in patients with HCC or CC. |
format | Online Article Text |
id | pubmed-6723795 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67237952019-09-10 APEX1 Expression as a Potential Diagnostic Biomarker of Clear Cell Renal Cell Carcinoma and Hepatobiliary Carcinomas Kim, Ji-Myung Yeo, Min-Kyung Lim, Jae Sung Song, In-Sang Chun, Kwangsik Kim, Kyung-Hee J Clin Med Article Apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APEX1) has been known to play key roles in DNA repair, the regulation of diverse transcriptional activity, and cellular responses to redox activity. This study aimed to examine serum APEX1 (s-APEX1) expression as a possible screening biomarker for clear cell renal cell carcinoma (ccRCC), hepatocellular carcinoma (HCC), and proximal and distal cholangiocarcinoma (CC). A total of 216 frozen serum samples were collected from 39 healthy control cases, 32 patients with ≥58 copies/mL of hepatitis B viral DNA (HBV DNA (+)), 40 ccRCC cases, 59 HCC cases, and 46 CC cases. The serum samples were examined for s-APEX1 concentration by enzyme-linked immunosorbent assay. The association of APEX1 expression with clinicopathological characteristics was also studied by immunohistochemical staining in 106 ccRCC, 131 HCC, and 32 intrahepatic CC cases. The median s-APEX1 concentrations of the HCC, CC, ccRCC, healthy control, and HBV DNA (+) groups were 0.294, 0.710, 0.474, 0.038, and 2.384 ng/mL, respectively (p < 0.001). Univariate and multivariate analyses revealed that increased cytoplasmic APEX1 expression led to a shorter disease-free survival period in HCC and CC cases. We suggest that the s-APEX1 level could be a potential diagnostic biomarker of ccRCC, HCC, and CC. Additionally, cytoplasmic APEX1 expression in cancer cells could be used to predict relapses in patients with HCC or CC. MDPI 2019-08-01 /pmc/articles/PMC6723795/ /pubmed/31375000 http://dx.doi.org/10.3390/jcm8081151 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kim, Ji-Myung Yeo, Min-Kyung Lim, Jae Sung Song, In-Sang Chun, Kwangsik Kim, Kyung-Hee APEX1 Expression as a Potential Diagnostic Biomarker of Clear Cell Renal Cell Carcinoma and Hepatobiliary Carcinomas |
title | APEX1 Expression as a Potential Diagnostic Biomarker of Clear Cell Renal Cell Carcinoma and Hepatobiliary Carcinomas |
title_full | APEX1 Expression as a Potential Diagnostic Biomarker of Clear Cell Renal Cell Carcinoma and Hepatobiliary Carcinomas |
title_fullStr | APEX1 Expression as a Potential Diagnostic Biomarker of Clear Cell Renal Cell Carcinoma and Hepatobiliary Carcinomas |
title_full_unstemmed | APEX1 Expression as a Potential Diagnostic Biomarker of Clear Cell Renal Cell Carcinoma and Hepatobiliary Carcinomas |
title_short | APEX1 Expression as a Potential Diagnostic Biomarker of Clear Cell Renal Cell Carcinoma and Hepatobiliary Carcinomas |
title_sort | apex1 expression as a potential diagnostic biomarker of clear cell renal cell carcinoma and hepatobiliary carcinomas |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723795/ https://www.ncbi.nlm.nih.gov/pubmed/31375000 http://dx.doi.org/10.3390/jcm8081151 |
work_keys_str_mv | AT kimjimyung apex1expressionasapotentialdiagnosticbiomarkerofclearcellrenalcellcarcinomaandhepatobiliarycarcinomas AT yeominkyung apex1expressionasapotentialdiagnosticbiomarkerofclearcellrenalcellcarcinomaandhepatobiliarycarcinomas AT limjaesung apex1expressionasapotentialdiagnosticbiomarkerofclearcellrenalcellcarcinomaandhepatobiliarycarcinomas AT songinsang apex1expressionasapotentialdiagnosticbiomarkerofclearcellrenalcellcarcinomaandhepatobiliarycarcinomas AT chunkwangsik apex1expressionasapotentialdiagnosticbiomarkerofclearcellrenalcellcarcinomaandhepatobiliarycarcinomas AT kimkyunghee apex1expressionasapotentialdiagnosticbiomarkerofclearcellrenalcellcarcinomaandhepatobiliarycarcinomas |